We used SDS-polyacrylamide gel electrophoresis to investigate the outer membrane proteins (OMPs) band composition of 19 Escherichia coli K1 strains that have spontaneously lost the ability to form K1 polysaccharide capsule (E. coli K1-) and demonstrated different degrees of susceptibility to the bactericidal action of normal human serum. Presented results showed that there were differences between E. coli K1- strains in OMPs expressing capacity. The analysis performed on OMPs has not revealed a direct association between the different OMPs band composition and the susceptibility of these strains to the serum.

Department of Biology and Medical Parasitology Wroclaw Medical University Mikulicza Radeckiego 9 50 367 Wrocław Poland

See more in PubMed

Bugla-Płoskońska G, Cisowska A, Karpińska K, Jankowski S, Doroszkiewicz W. The mechanisms of the activation of normal human serum complement by Escherichia coli strains with K1 surface antigen. Folia Microbiol. 2006;51:627–632. doi: 10.1007/BF02931630. PubMed DOI

Bugla-Płoskońska G, Rybka J, Futoma-Kołoch B, Cisowska A, Gamian A, Doroszkiewicz W. Sialic acid-containing lipopolysaccharides of Salmonella O48 strains—potential role in camouflage and susceptibility to the bactericidal action of normal human serum. Microb Ecol. 2010;59:601–613. doi: 10.1007/s00248-009-9600-2. PubMed DOI

Chaffer M, Heller ED, Schwartsburd B. Relationship between resistance to complement, virulence and outer membrane protein patterns in pathogenic Escherichia coli O2 isolates. Vet Microbiol. 1999;64:323–332. doi: 10.1016/S0378-1135(98)00278-8. PubMed DOI

Cisowska A, Bugla-Płoskońska G, Tichaczek-Goska D, Doroszkiewicz W, Jankowski S (2004) The susceptibility of Escherichia coli strains with sialic acid-containing lipopolysaccharides or capsules to the bactericidal action of normal human serum. 7th Conference on Molecular Biology in Diagnostics of Infectious Diseases and Biotechnology. SGGW, Warsaw, pp 41–47

Cisowska A, Bugla-Płoskońska G, Gamian A, Doroszkiewicz W, Jankowski S. Relationship between susceptibility to bactericidal action of serum and outer membrane protein patterns in E. coli K1 strains. Pol J Environ Stud. 2005;14:476–482.

Devine DA, Roberts AP, Rowe B. Simple technique for detecting K1 antigen of Escherichia coli. J Clin Pathol. 1990;43:76–78. doi: 10.1136/jcp.43.1.76. PubMed DOI PMC

Drogari-Apiranthitou M, Kuijper EJ, Dekker N, Dankert J. Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity. Infect Immun. 2002;70:3752–3758. doi: 10.1128/IAI.70.7.3752-3758.2002. PubMed DOI PMC

Ferrero MA, Aparicio LR. Biosynthesis and production of polysialic acids in bacteria. Appl Microbiol Biotechnol. 2010;86:1621–1635. doi: 10.1007/s00253-010-2531-5. PubMed DOI

Hill DJ, Griffiths NJ, Borodina E, Virji M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci. 2010;118:547–564. PubMed PMC

Jarva H, Ram S, Vogel U, Blom AM, Meri S. Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J Immunol. 2005;174:6299–6307. PubMed

Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991;4:80–128. PubMed PMC

Kucheria R, Dasgupta P, Sacks SH, Khan MS, Sheerin NS. Urinary tract infections: new insights into a common problem. Postgrad Med J. 2005;81:83–86. doi: 10.1136/pgmj.2004.023036. PubMed DOI PMC

Kugelberg E, Gollan B, Tang CM. Mechanisms in Neisseria meningitides for resistance against complement-mediated killing. Vaccine. 2008;26:134–139. doi: 10.1016/j.vaccine.2008.11.059. PubMed DOI PMC

Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. PubMed DOI

Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, Ngampasutadol J, Vogel U, Granoff DM, Ram S. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol. 2006;177:501–510. PubMed PMC

Moll A, Manning PA, Timmis KN. Plasmid-determined resistance to serum bactericidal activity: a major outer-membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli. Infect Immun. 1980;28:359–367. PubMed PMC

Murphy T, Bartos LC. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarralis. Infect Immun. 1989;57:2938–2941. PubMed PMC

Nassif X, Bourdouloud S, Eugene E, Couraud PO. How do extracellular pathogens cross the blood–brain barrier? Trends Microbiol. 2002;10:227–232. doi: 10.1016/S0966-842X(02)02349-1. PubMed DOI

Parthasarathy G, Yao Y, Kim KS. Flagella promote Escherichia coli K1 association with and invasion of human brain microvascular endothelial cells. Infect Immun. 2007;75:2937–2945. doi: 10.1128/IAI.01543-06. PubMed DOI PMC

Pierce Instructions. Pierce®BCA Protein Assay kit. Thermo Scientific, Pierce Biotechnology.

Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC. A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J Immunol. 2002;169:6352–6360. PubMed

Rautemaa R, Meri S. Complement-resistance mechanisms of bacteria. Microbes Infect. 1999;1:785–794. doi: 10.1016/S1286-4579(99)80081-1. PubMed DOI

Rockwood D, Wilson MT, Darley-Usmar VM. Isolation and characteristic of intact mitochondria. In: Darley-Usmar VM, Rickwood D, Wilson MT, editors. Mitochondria: a practical approach. Oxford: IRL; 1987. pp. 1–16.

Singh B, Y-Ch S, Riesbeck K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol. 2010;78:545–560. doi: 10.1111/j.1365-2958.2010.07373.x. PubMed DOI

Taylor PW. Complement-mediated killing of susceptible Gram-negative bacteria: an elusive mechanism. Exp Clin Immunogenet. 1992;9:48–56. PubMed

Taylor PW (1995) Resistance of bacteria to complement. In: Roth JA (ed) Virulence mechanism of bacterial pathogen. Am Soc Microbiol Washington DC.

Uria MJ, Zhang Q, Li Y, Chan A, Exley RM, Gollan B, Chan H, Feavers I, Yarwood A, Abad R, Borrow R, Fleck RA, Mulloy B, Vazquez JA, Tang CM. A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med. 2008;205:1423–1434. doi: 10.1084/jem.20072577. PubMed DOI PMC

Vermeulen C, Cross A, Byrne WR, Zollinger W. Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli. Infect Immun. 1988;56:2723–2730. PubMed PMC

Weiser JN, Gotschlich EC. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun. 1991;57:2252–2258. PubMed PMC

Wooster DG, Maruvada R, Blom AM, Prasadarao NV. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunol. 2006;117:482–493. doi: 10.1111/j.1365-2567.2006.02323.x. PubMed DOI PMC